FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Soave Darlene
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/25/2021 

3. Issuer Name and Ticker or Trading Symbol

Cell Source, Inc. [CLCS]
(Last)        (First)        (Middle)

57 WEST 57TH STREET, SUITE 400
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

NEW YORK, NY 10019      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 258414 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (right to buy) 6/18/2020 6/18/2025 Common Stock 1200000 $1.25 D  
Warrant (right to buy) 3/2/2021 3/2/2026 Common Stock 800000 $1.25 D  
Series A Convertible Preferred Stock 11/8/2018  (1)Common Stock 1333340 $0.75 D  

Explanation of Responses:
(1) The Series A Convertible Preferred Stock does not have an expiration date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Soave Darlene
57 WEST 57TH STREET, SUITE 400
NEW YORK, NY 10019
X



Signatures
/s/ Darlene Soave4/20/2021
**Signature of Reporting PersonDate

Cell Source (CE) (USOTC:CLCS)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Cell Source (CE) Charts.
Cell Source (CE) (USOTC:CLCS)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Cell Source (CE) Charts.